Guanghui Cao

Zhengzhou University - Department of Urology

Zhengzhou, 450003

China

SCHOLARLY PAPERS

1

DOWNLOADS

10

SSRN CITATIONS

0

CROSSREF CITATIONS

0

Scholarly Papers (1)

1.

Role of Immune Checkpoint Inhibitor-Based Therapies for Metastatic Renal Cell Carcinoma in the First-Line Setting: A Systematic Review and Bayesian Network Analysis

EBioMedicine, Volume 47, September 2019, Pages 78-88, https://doi.org/10.1016/j.ebiom.2019.08.006
Number of pages: 36 Posted: 18 Jun 2019
Zhengzhou University, Zhengzhou University, Zhengzhou University - Department of Urology, Zhengzhou University, Zhengzhou University - Department of Urology, Zhengzhou University - Department of Urology, Zhengzhou University - Department of Pathophysiology, Zhengzhou University - Department of Pathophysiology and Zhengzhou University - Department of Urology
Downloads 10 (628,943)

Abstract:

Loading...

renal cell carcinoma; first-line systemic therapies; immune checkpoint inhibitor; efficacy; safety